PG
EDIT icon

Patten Group’s Editas Medicine EDIT Stock Holding History

Patten Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-525
Closed -$12K – 281
2018
Q4 		$12K Sell
525
-195
-27% -$5.31K 0.01% 415
2018
Q3 		$23K Sell
720
-375
-34% -$12.1K 0.01% 405
2018
Q2 		$39K Hold
1,095
– – 0.02% 349
2018
Q1 		$36K Sell
1,095
-120
-10% -$4.28K 0.01% 354
2017
Q4 		$37K Buy
1,215
+610
+101% +$15.4K 0.01% 368
2017
Q3 		$15K Buy
+605
New +$11.5K 0.01% 443

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

Patten Group's EDIT Position: Q1 2019 in Review

Patten Group sold out of Editas Medicine (EDIT) in Q1 2019, closing a stake of 525 shares — an estimated $12K sold.

Patten Group first reported a position in EDIT in Q3 2017 and held it in 6 quarters. The position peaked at $39K in Q2 2018. 201 funds tracked by Wall St. Rank hold EDIT as of Q1 2019.

  • Patten Group reported no remaining Editas Medicine position as of Q1 2019 after selling out during the quarter.
  • Patten Group sold 525 Editas Medicine shares in Q1 2019, an estimated $12K.
  • Patten Group first reported a position in Editas Medicine in Q3 2017 and held it in 6 quarters.
  • Patten Group's Editas Medicine position peaked at $39K in Q2 2018.
  • 201 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2019.

Based on Patten Group's 13F filing for Q1 2019, filed 14 May 2019.